HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low-dose zoledronic acid reduces spinal cord metastasis in pulmonary adenocarcinoma with neuroendocrine differentiation.

Abstract
Zoledronic acid (ZOL), a nitrogen-containing compound, is effective in the treatment of skeletal disorders, but its long-term use in high doses gives rise to complications such as osteonecrosis. We aimed to investigate the effect of low-dose ZOL on the expression of the neural cell adhesion molecule (NCAM), which may be correlated with tumor growth and spinal cord metastasis in lung adenocarcinoma with neuroendocrine differentiation. First, we used the small hairpin RNA technique to directly knock down NCAM expression in cells of a murine lung adenocarcinoma line, line 1 cells, and found that the tumor cells generated showed lower invasive capacity, slower tumor growth, and lesser tendency for spinal cord metastasis than control cells. Further, ZOL decreased NCAM expression and invasiveness in line 1 tumor cells in vitro. Line 1/lacZ cells, a stable clone tagged with the lacZ gene, were introduced into mice, followed by ZOL treatment (1 μg/kg/weekly). Low-dose ZOL significantly reduced spinal cord metastasis probably through reduced NCAM expression in vivo. These findings indicated that NCAM is involved in tumor growth and spinal cord metastasis of lung adenocarcinoma with neuroendocrine differentiation. Treatment with low-dose ZOL can reduce NCAM expression that may contribute toward reduced spinal cord metastasis, suggesting that NCAM is an alternative therapeutic target and that the low-dose ZOL treatment protocol is a reasonable approach for its treatment.
AuthorsYing-Ying Li, John W-C Chang, Ling-Ling Hsieh, Shu-Mei Chen, Kun-Yun Yeh
JournalAnti-cancer drugs (Anticancer Drugs) Vol. 23 Issue 9 Pg. 970-8 (Oct 2012) ISSN: 1473-5741 [Electronic] England
PMID22713592 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Diphosphonates
  • Imidazoles
  • Neural Cell Adhesion Molecules
  • RNA, Small Interfering
  • Green Fluorescent Proteins
  • Zoledronic Acid
Topics
  • Animals
  • Antineoplastic Agents (administration & dosage, pharmacology, therapeutic use)
  • Carcinoma, Neuroendocrine (drug therapy, metabolism, secondary)
  • Cell Differentiation
  • Cell Line, Tumor
  • Cloning, Molecular
  • Diphosphonates (administration & dosage, pharmacology, therapeutic use)
  • Dose-Response Relationship, Drug
  • Flow Cytometry
  • Gene Knockdown Techniques
  • Green Fluorescent Proteins (genetics)
  • Imidazoles (administration & dosage, pharmacology, therapeutic use)
  • Lung Neoplasms (drug therapy, metabolism, pathology)
  • Mice
  • Mice, Inbred BALB C
  • Neoplasm Invasiveness
  • Neoplasm Transplantation
  • Neural Cell Adhesion Molecules (antagonists & inhibitors, biosynthesis, genetics)
  • RNA, Small Interfering (genetics)
  • Spinal Cord Neoplasms (drug therapy, metabolism, secondary)
  • Transfection
  • Zoledronic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: